- Home
- RNAZ vs NCPL Comparison
RNAZ vs NCPL Comparison
Compare RNAZ & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- NCPL
- Stock Information
- Founded
- RNAZ 2016
- NCPL 1984
- Country
- RNAZ United States
- NCPL United States
- Employees
- RNAZ N/A
- NCPL N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- NCPL Investment Managers
- Sector
- RNAZ Health Care
- NCPL Finance
- Exchange
- RNAZ Nasdaq
- NCPL Nasdaq
- Market Cap
- RNAZ 8.7M
- NCPL 9.2M
- IPO Year
- RNAZ 2021
- NCPL N/A
- Fundamental
- Price
- RNAZ $8.60
- NCPL $1.80
- Analyst Decision
- RNAZ Strong Buy
- NCPL
- Analyst Count
- RNAZ 1
- NCPL 0
- Target Price
- RNAZ $280.00
- NCPL N/A
- AVG Volume (30 Days)
- RNAZ 19.3K
- NCPL 64.1K
- Earning Date
- RNAZ 11-14-2025
- NCPL 12-15-2025
- Dividend Yield
- RNAZ N/A
- NCPL N/A
- EPS Growth
- RNAZ N/A
- NCPL N/A
- EPS
- RNAZ N/A
- NCPL N/A
- Revenue
- RNAZ N/A
- NCPL $917,291.00
- Revenue This Year
- RNAZ N/A
- NCPL $739.37
- Revenue Next Year
- RNAZ N/A
- NCPL N/A
- P/E Ratio
- RNAZ N/A
- NCPL N/A
- Revenue Growth
- RNAZ N/A
- NCPL N/A
- 52 Week Low
- RNAZ $6.15
- NCPL $1.50
- 52 Week High
- RNAZ $468.44
- NCPL $8.75
- Technical
- Relative Strength Index (RSI)
- RNAZ 34.45
- NCPL 35.23
- Support Level
- RNAZ $8.41
- NCPL $1.78
- Resistance Level
- RNAZ $9.85
- NCPL $2.09
- Average True Range (ATR)
- RNAZ 0.68
- NCPL 0.15
- MACD
- RNAZ -0.30
- NCPL -0.02
- Stochastic Oscillator
- RNAZ 11.05
- NCPL 10.67
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.